Skip to content

Virtual Reality Assisted Conscious Sedation During TAVI

Virtual Reality Assisted Conscious Sedation During Transcatheter Aortic Valve Implantation - a Randomized Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04259723
Acronym
TAVI_VR
Enrollment
20
Registered
2020-02-06
Start date
2019-11-01
Completion date
2020-06-01
Last updated
2020-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Pain, Severe Aortic Valve Stenosis

Keywords

TAVI, VR, 3D glasses

Brief summary

Transcatheter aortic valve implantation (TAVI) is an established therapy for patients with severe aortic valve stenosis. Pain and anxiety are major contributors to procedural complications. Virtual Reality (VR) glasses have already been used successfully in different clinical settings to treat anxiety and delirium. The aim of this prospective, randomized investigation is to prove the feasibility and safety of VR interventions in patients undergoing conscious sedation during TAVI with local anesthesia only.

Interventions

OTHERVR during TAVI

Virtual Reality (VR) glasses

Sponsors

Klinik für Kardiologie, Pneumologie und Angiologie
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Interventional transfemoral TAVI * Informed consent * Normal or corrected vision (through glasses)

Exclusion criteria

* Patients whose communication is limited due to a language barrier * Patients who could not watch the 3D video due to uncorrectable vision * all patients with transapical TAVI were also excluded.

Design outcomes

Primary

MeasureTime frameDescription
Change in anxietyat BaselineA visual analog scale will be used to determine the level of anxiety before and after the procedure. The visual analogue scale or visual analog scale (VAS) is a psychometric response scale which can be used in questionnaires. It is a measurement instrument for subjective characteristics or attitudes that cannot be directly measured. When responding to a VAS item, respondents specify their level of agreement to a statement by indicating a position along a continuous line between two end-points (0=no anxiety, 10=maximum anxiety/extremly anxious)

Secondary

MeasureTime frameDescription
Evaluation of clinical frailty scaleat BaselineThe Clinical Frailty Scale (CFS) is a simple model visually describing patients physical conditions with nine classes from very fit (class 1) to terminally ill (class 9).
Measurement of pain: visual analog scaleafter 24 hoursA visual analog scale will be used to determine the level of pain after the procedure. A visual analog scale will be used to determine the level of anxiety before and after the procedure. The visual analogue scale or visual analog scale (VAS) is a psychometric response scale which can be used in questionnaires. It is a measurement instrument for subjective characteristics or attitudes that cannot be directly measured. When responding to a VAS item, respondents specify their level of agreement to a statement by indicating a position along a continuous line between two end-points (0=no pain, 10=unbearable pain)
Length of stay at hospitalup to 5 daysThe length of stay at hospital will be recorded.
Time of VRat BaselineThe time \[min\] of VR use will be recorded during the procedure
Occurence of nauseaat Baseline, periprocedural and after 24 hoursPatients will be asked during and after the procedure for safety problems with special regards to nausea
Rate of Intra-hospital mortalityup to 5 daysThe intra-hospital mortality will be assessed after discharge
Occurence of vomittingat Baseline, periprocedural and after 24 hoursPatients will be asked during and after the procedure for safety problems with special regards to vomiting

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026